239 related articles for article (PubMed ID: 18355687)
1. A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
Zeng Z; O'Brien JA; Lemaire W; O'Malley SS; Miller PJ; Zhao Z; Wallace MA; Raab C; Lindsley CW; Sur C; Williams DL
Nucl Med Biol; 2008 Apr; 35(3):315-25. PubMed ID: 18355687
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of two glycine transporter 1 radiotracers [11C]GSK931145 and [18F]MK-6577 in baboons.
Zheng MQ; Lin SF; Holden D; Naganawa M; Ropchan JR; Najafzaden S; Kapinos M; Tabriz M; Carson RE; Hamill TG; Huang Y
Synapse; 2016 Mar; 70(3):112-20. PubMed ID: 26671330
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of [¹²⁵I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1.
Fuchigami T; Haratake M; Magata Y; Haradahira T; Nakayama M
Bioorg Med Chem; 2011 Nov; 19(21):6245-53. PubMed ID: 21975065
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF
Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers.
Hamill TG; Eng W; Jennings A; Lewis R; Thomas S; Wood S; Street L; Wisnoski D; Wolkenberg S; Lindsley C; Sanabria-Bohórquez SM; Patel S; Riffel K; Ryan C; Cook J; Sur C; Burns HD; Hargreaves R
Synapse; 2011 Apr; 65(4):261-70. PubMed ID: 20687108
[TBL] [Abstract][Full Text] [Related]
7. Measurement of Bmax and Kd with the glycine transporter 1 radiotracer ¹⁸F-MK6577 using a novel multi-infusion paradigm.
Xia Y; Zheng MQ; Holden D; Lin SF; Kapinos M; Ropchan J; Gallezot JD; Huang Y; Carson RE
J Cereb Blood Flow Metab; 2015 Dec; 35(12):2001-9. PubMed ID: 26198176
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans.
Joshi AD; Sanabria-Bohórquez SM; Bormans G; Koole M; De Hoon J; Van Hecken A; Depre M; De Lepeleire I; Van Laere K; Sur C; Hamill TG
Synapse; 2015 Jan; 69(1):33-40. PubMed ID: 25196464
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides.
Lindsley CW; Zhao Z; Leister WH; O'Brien J; Lemaire W; Williams DL; Chen TB; Chang RS; Burno M; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Tsou NN; Duggan ME; Conn PJ; Hartman GD
ChemMedChem; 2006 Aug; 1(8):807-11. PubMed ID: 16902933
[No Abstract] [Full Text] [Related]
10. Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors.
Zhao Z; Leister WH; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Lindsley CW; Wolkenberg SE
Bioorg Med Chem Lett; 2009 Mar; 19(5):1488-91. PubMed ID: 19179073
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
[TBL] [Abstract][Full Text] [Related]
13. Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1.
Varnes JG; Forst JM; Hoerter TN; Holmquist CR; Wilkins DE; Tian G; Jonak G; Wang X; Potts WM; Wood MW; Alhambra C; Brugel TA; Albert JS
Bioorg Med Chem Lett; 2010 Aug; 20(16):4878-81. PubMed ID: 20637614
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
Komatsu H; Furuya Y; Sawada K; Asada T
Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
[TBL] [Abstract][Full Text] [Related]
15. Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans.
Wong DF; Ostrowitzki S; Zhou Y; Raymont V; Hofmann C; Borroni E; Kumar A; Parkar N; Brašić JR; Hilton J; Dannals RF; Martin-Facklam M
Neuroimage; 2013 Jul; 75():282-290. PubMed ID: 22155032
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1.
Fuchigami T; Takano A; Gulyás B; Jia Z; Finnema SJ; Andersson JD; Nakao R; Magata Y; Haratake M; Nakayama M; Halldin C
EJNMMI Res; 2012 Jul; 2(1):37. PubMed ID: 22776065
[TBL] [Abstract][Full Text] [Related]
17. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
[TBL] [Abstract][Full Text] [Related]
18. Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.
Haradahira T; Okauchi T; Maeda J; Zhang MR; Nishikawa T; Konno R; Suzuki K; Suhara T
Synapse; 2003 Nov; 50(2):130-6. PubMed ID: 12923815
[TBL] [Abstract][Full Text] [Related]
19. Development of N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methyl-4-[11C]methylbenzamide for positron emission tomography imaging of metabotropic glutamate 1 receptor in monkey brain.
Fujinaga M; Yamasaki T; Maeda J; Yui J; Xie L; Nagai Y; Nengaki N; Hatori A; Kumata K; Kawamura K; Zhang MR
J Med Chem; 2012 Dec; 55(24):11042-51. PubMed ID: 23194448
[TBL] [Abstract][Full Text] [Related]
20. Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography.
Passchier J; Gentile G; Porter R; Herdon H; Salinas C; Jakobsen S; Audrain H; Laruelle M; Gunn RN
Synapse; 2010 Jul; 64(7):542-9. PubMed ID: 20196141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
